PRME
Prime Medicine Inc.
$3.06
-$0.41(-11.82%)
56
Overall
55
Value
72
Tech
42
Quality
Market Cap
$731.07M
Volume
4.49M
52W Range
$1.18 - $6.94
Target Price
$6.92
EPS Estimates Overview
| Current Quarter | $-0.24 | Next Quarter | $-0.23 |
| Current Year | $-0.98 | Next Year | $-0.92 |
| QoQ Growth | +4.2% | YoY Growth | +6.1% |
| 3Y EPS CAGR | +31.4% | Target Price | $6.92 |
| Consensus | Buy | Upside | +126.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRME | $3.06 | -11.8% | 4.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |